Search results

2455 results

Sorted by Relevance . Sort by Date

  1. Hepatitis B and C testing

    Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection.

  2. Home care for older people

    Everything NICE has said on planning and delivering home care for older people in an interactive flowchart

  3. Intravenous fluid therapy in hospital

    Everything NICE has said on managing intravenous fluid therapy in children, young people and adults in hospital in an interactive flowchart

  4. Kidney conditions

    Everything NICE has said on kidney (renal) conditions in an interactive flowchart

  5. Irritable bowel syndrome in adults

    Everything NICE has said on diagnosing and managing irritable bowel syndrome in adults in primary care in an interactive flowchart

  6. Influenza

    Everything NICE has said on influenza in an interactive flowchart

  7. Trauma

    Everything NICE has said on assessing and managing trauma in an interactive flowchart

  8. Gastrointestinal cancers

    Everything NICE has said on gastrointestinal cancers in an interactive flowchart

  9. Gallstone disease

    Everything NICE has said on diagnosing and managing gallstone disease in adults in an interactive flowchart

  10. Glaucoma

    Everything NICE has said on assessing, treating and managing glaucoma in adults in an interactive flowchart

  11. Generalised anxiety disorder

    Everything NICE has said on managing generalised anxiety disorder in adults in primary, secondary and community care in an interactive flowchart

  12. Harmful sexual behaviour among children and young people

    Everything NICE has said on harmful sexual behaviour among children and young people (under 18s or under 25s with special educational needs or a disability) in an interactive flowchart.

  13. Hearing loss

    Everything NICE has said on hearing loss or impairment in adults in an interactive flowchart

  14. Foot care for people with diabetes

    Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart

  15. Perioperative care

    Everything NICE has said on perioperative care in adults in an interactive flowchart.

  16. Leg ulcers

    Everything NICE has said on leg ulcers in an interactive flowchart

  17. Transient loss of consciousness

    Everything NICE has said on assessing, diagnosing and referring adults and young people who have experienced a blackout in an interactive flowchart

  18. Atrial fibrillation

    Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart

  19. Hypertension

    Everything NICE has said on managing hypertension in adults in an interactive flowchart

  20. Upper aerodigestive tract cancer

    Everything NICE has said on assessing and managing upper aerodigestive tract cancer in young people and adults in an interactive flowchart

  21. Lung cancer

    Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart

  22. Prostate cancer

    Everything NICE has said on diagnosing and treating prostate cancer in an interactive flowchart

  23. Food allergy in under 19s

    Everything NICE has said on diagnosing and assessing food allergy in children and young people in primary care and community settings in an interactive flowchart

  24. Asthma

    Everything NICE has said on diagnosing, monitoring and managing asthma in children, young people and adults in an interactive flowchart

  25. Nutrition support in adults

    Everything NICE has said on nutrition support for adults who are malnourished or at risk of malnutrition in an interactive flowchart

  26. Chronic kidney disease

    Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart

  27. Type 2 diabetes mellitus: medicines optimisation priorities (KTT12)

    This document summarises the evidence base on type 2 diabetes mellitus: medicines optimisation priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  28. Hypnotics (KTT6)

    This document summarises the evidence base on hypnotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  29. Chemotherapy dose standardisation (KTT22)

    This document summarises the evidence base on chemotherapy dose standardisation . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  30. Safer insulin prescribing (KTT20)

    This document summarises the evidence base on safer insulin prescribing . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  31. Multimorbidity and polypharmacy (KTT18)

    This document summarises the evidence base on multimorbidity and polypharmacy . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  32. Anticoagulants, including direct-acting oral anticoagulants (DOACs) (KTT16)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on anticoagulants , including direct-acting oral anticoagulants (DOACs). It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  33. Biosimilar medicines (KTT15)

    The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  34. Wound care products (KTT14)

    This document summarises the evidence base on wound care products . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  35. Non-steroidal anti-inflammatory drugs (KTT13)

    The key therapeutic topic non-steroidal anti-inflammatory drugs has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  36. Antimicrobial stewardship: prescribing antibiotics (KTT9)

    This document summarises the evidence base on antimicrobial stewardship: prescribing antibiotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  37. Antipsychotics in people living with dementia (KTT7)

    This document summarises the evidence base on antipsychotics in people living with dementia . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  38. Asthma: medicines safety priorities (KTT5)

    This document summarises the evidence base on asthma: medicines safety priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  39. Lipid-modifying drugs (KTT3)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on lipid-modifying drugs. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  40. Medicines optimisation in chronic pain (KTT21)

    This document summarises the evidence base on medicines optimisation in chronic pain . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .